Opposing View: A Blind Faith in Meta-Analyses in Academia Could Be a Threat to Public Health.
作者信息
Bae Jae Hyun
机构信息
Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
出版信息
J Lipid Atheroscler. 2022 Sep;11(3):308-313. doi: 10.12997/jla.2022.11.3.308. Epub 2022 Sep 15.
Abstract
摘要
相似文献
1
Opposing View: A Blind Faith in Meta-Analyses in Academia Could Be a Threat to Public Health.反对观点：学术界对荟萃分析的盲目信任可能对公众健康构成威胁。
J Lipid Atheroscler. 2022 Sep;11(3):308-313. doi: 10.12997/jla.2022.11.3.308. Epub 2022 Sep 15.
2
Combating Contagion and Injustice: The Shared Work for Public Health and Faith Communities During COVID-19.抗击传染病与不公正现象：新冠疫情期间公共卫生与宗教团体的共同工作
J Relig Health. 2021 Jun;60(3):1436-1445. doi: 10.1007/s10943-021-01243-4. Epub 2021 Mar 27.
3
The internal migration between public and faith-based health providers: a cross-sectional, retrospective and multicentre study from southern Tanzania.公立和信仰型卫生提供者之间的内部迁移：来自坦桑尼亚南部的一项横断面、回顾性和多中心研究。
Trop Med Int Health. 2013 Jul;18(7):887-97. doi: 10.1111/tmi.12107.
4
Enhancing the role of faith-based organizations to improve health: a commentary.强化信仰组织的作用以改善健康：评论。
Transl Behav Med. 2017 Sep;7(3):529-531. doi: 10.1007/s13142-017-0485-1.
5
Perspectives of community- and faith-based organizations about partnering with local health departments for disasters.社区和信仰组织对与地方卫生部门合作应对灾害的看法。
Int J Environ Res Public Health. 2012 Jul;9(7):2293-311. doi: 10.3390/ijerph9072293. Epub 2012 Jun 28.
6
Religious faith and sexual risk taking among adolescents and emerging adults: A meta-analytic review.宗教信仰与青少年和成年早期的性冒险行为：一项元分析综述。
Soc Sci Med. 2021 Dec;291:114488. doi: 10.1016/j.socscimed.2021.114488. Epub 2021 Oct 14.
7
Multilevel Faith-Based Public Health Initiative in Rural Alabama, 2017.2017 年，阿拉巴马州农村地区基于信仰的多层次公共卫生倡议。
Prev Chronic Dis. 2019 Aug 29;16:E117. doi: 10.5888/pcd16.190057.
8
Rating threat mitigators: faith in experts, governments, and individuals themselves to create a safer world.
Risk Anal. 1998 Oct;18(5):547-56. doi: 10.1023/b:rian.0000005929.21712.78.
9
Prices, availability and affordability of medicines in Rwanda.卢旺达药品的价格、供应情况和可负担性。
PLoS One. 2020 Aug 3;15(8):e0236411. doi: 10.1371/journal.pone.0236411. eCollection 2020.
10
Physical Activity Interventions in Faith-Based Organizations: A Systematic Review.基于宗教组织的体育活动干预措施：一项系统综述。
Am J Health Promot. 2018 Mar;32(3):677-690. doi: 10.1177/0890117116688107. Epub 2017 Jan 13.
引用本文的文献
1
Public Awareness of Dyslipidemia Among the Korean Population: A Survey Study.韩国人群血脂异常的公众认知：一项调查研究。
J Lipid Atheroscler. 2023 Sep;12(3):307-314. doi: 10.12997/jla.2023.12.3.307. Epub 2023 Aug 25.
本文引用的文献
1
Emphasizing Study Selection in a Review of Statin Treatment Effects and Low-Density Lipoprotein Cholesterol-Reply.在关于他汀类药物治疗效果及低密度脂蛋白胆固醇的综述中强调研究选择——回复
JAMA Intern Med. 2022 Aug 1;182(8):891. doi: 10.1001/jamainternmed.2022.2217.
2
Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis.评估低密度脂蛋白胆固醇降低与他汀类药物治疗的相对和绝对效果之间的关联：系统评价和荟萃分析。
JAMA Intern Med. 2022 May 1;182(5):474-481. doi: 10.1001/jamainternmed.2022.0134.
3
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
4
5
Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data.《2020年韩国血脂异常情况说明书：基于全国人口数据的分析》
J Lipid Atheroscler. 2021 May;10(2):202-209. doi: 10.12997/jla.2021.10.2.202. Epub 2021 Apr 2.
6
2018 Guidelines for the Management of Dyslipidemia in Korea.《2018年韩国血脂异常管理指南》
J Lipid Atheroscler. 2019 Sep;8(2):78-131. doi: 10.12997/jla.2019.8.2.78. Epub 2019 Aug 7.
7
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病：病理生理学、遗传学及治疗学见解：欧洲动脉粥样硬化学会共识小组的共识声明
Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962.
8
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
9
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.他汀类药物依从性与动脉粥样硬化性心血管疾病患者死亡率的关系。
JAMA Cardiol. 2019 Mar 1;4(3):206-213. doi: 10.1001/jamacardio.2018.4936.
10
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.他汀类药物治疗老年人的疗效和安全性：28 项随机对照试验个体参与者数据的荟萃分析。
Lancet. 2019 Feb 2;393(10170):407-415. doi: 10.1016/S0140-6736(18)31942-1.
Zotero 插件